The Copenhagen Actinic Keratosis Study (COAKS). A decentralised clinical trial to evaluate tolerability, safety and efficacy of daily field-directed topical treatment with cytosolic phospholipase A 2 inhibitor, AVX001, in participants with actinic keratosis: protocol for a randomised controlled phase I/IIa trial.
Vinzent Kevin OrtnerBerit JohansenKim KilovAlejandro Castillo MondragónTore DuvoldJesper KihlFelicity J AshcroftAstrid Jullumstrø FeuerhermCharlotte Amalie Pind LaugesenMaiken Lise Marcker EspersenIonela ManoleAri Páll IsbergAnders Daniel AndersenElin RakvaagJohn Robert ZibertMerete HaedersdalPublished in: BMJ open (2022)
2021-000934-32; NCT05164393.